Invesco
XBIT icon

Invesco’s XBiotech XBIT Stock Holding History

Invesco’s Portfolio XBIT Stock Details XBIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-24,831
Closed -$277K – 4116
2021
Q4 		$277K Sell
24,831
-2,957
-11% -$38.5K ﹤0.01% 3650
2021
Q3 		$359K Buy
27,788
+1,285
+5% +$20.5K ﹤0.01% 3580
2021
Q2 		$439K Buy
26,503
+1,896
+8% +$32.2K ﹤0.01% 3471
2021
Q1 		$422K Buy
24,607
+14,008
+132% +$262K ﹤0.01% 3409
2020
Q4 		$166K Buy
+10,599
New +$195K ﹤0.01% 3572
2020
Q3 		– Sell
-10,944
Closed -$151K – 3694
2020
Q2 		$151K Buy
+10,944
New +$154K ﹤0.01% 3537
2015
Q3 		– Sell
-274
Closed -$5K – 4009
2015
Q2 		$5K Buy
+274
New +$5.68K ﹤0.01% 4219

Other funds holding XBIT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Invesco's XBIT Position: Q1 2022 in Review

Invesco sold out of XBiotech (XBIT) in Q1 2022, closing a stake of 24,831 shares — an estimated $277K sold.

Invesco first reported a position in XBIT in Q2 2015 and held it in 7 quarters. The position peaked at $439K in Q2 2021. 64 funds tracked by Wall St. Rank hold XBIT as of Q1 2022.

  • Invesco reported no remaining XBiotech position as of Q1 2022 after selling out during the quarter.
  • Invesco sold 24,831 XBiotech shares in Q1 2022, an estimated $277K.
  • Invesco first reported a position in XBiotech in Q2 2015 and held it in 7 quarters.
  • Invesco's XBiotech position peaked at $439K in Q2 2021.
  • 64 funds tracked by Wall St. Rank held XBiotech as of Q1 2022.

Based on Invesco's 13F filing for Q1 2022, filed 16 May 2022.